COMPARATIVE STUDY OF TOPIRAMATE VERSUS SODIUM VALPROATE IN THE PREVENTION OF MIGRAINE HEADACHES

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

FAZL ALIZADEH H.; KHAMSEH F.; SOLEYMANI B.; TAJIK A.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: MEDICAL SCIENCES JOURNAL OF ISLAMIC AZAD UNIVERSITY Year:2009 | Volume:19 | Issue:2 (56) Page(s): 105-109

Download Full-Text

Persian Verion

View:

1,865

Download:

Cites:

Information Journal Paper

Title

COMPARATIVE STUDY OF TOPIRAMATE VERSUS SODIUM VALPROATE IN THE PREVENTION OF MIGRAINE HEADACHES

Author(s)

FAZL ALIZADEH H. | KHAMSEH F. | SOLEYMANI B. | TAJIK A. | Issue Writer Certificate

Keywords

MIGRAINEQ2

SODIUM VALPROATEQ2

TOPIRAMATEQ2

Abstract

Background: MIGRAINE prevention is a major step in control and decreasing frequency of this severe and disabling type of headache. Current study was performed to determine the comparative efficacy of TOPIRAMATE and SODIUM VALPROATE in the management of MIGRAINE headache.Materials and methods: In this double-blind randomized clinical trial, among patients attending to Amir-al-momenin hospital between 2006 and 2007, 285 patients (50.1%) received SODIUM VALPROATE with a dose of 200 mg/day and 284 subjects (49.9%) received TOPIRAMATE with a dose of 100 mg/day for one month. Results: 262 patients (91.9%) in SODIUM VALPROATE group and 266 subjects (93.7%) in TOPIRAMATE group had good response to treatment (NS). In SODIUM VALPROATE group, 40 patients (14%) and in TOPIRAMATE group, 41 subjects (14.4%) experienced drug adverse effects (NS). Conclusion: According to lack of statistically significant differences between therapeutic efficacy and adverse effects of SODIUM VALPROATE and TOPIRAMATE, both modalities may be indicated upon with patient's conditions and physician's opinion.

Cites

No record.

References

No record.

Cite

APA: Copy

FAZL ALIZADEH, H., KHAMSEH, F., SOLEYMANI, B., & TAJIK, A.. (2009). COMPARATIVE STUDY OF TOPIRAMATE VERSUS SODIUM VALPROATE IN THE PREVENTION OF MIGRAINE HEADACHES. MEDICAL SCIENCES JOURNAL OF ISLAMIC AZAD UNIVERSITY, 19(2 (56)), 105-109. SID. https://sid.ir/paper/98855/en

Vancouver: Copy

FAZL ALIZADEH H., KHAMSEH F., SOLEYMANI B., TAJIK A.. COMPARATIVE STUDY OF TOPIRAMATE VERSUS SODIUM VALPROATE IN THE PREVENTION OF MIGRAINE HEADACHES. MEDICAL SCIENCES JOURNAL OF ISLAMIC AZAD UNIVERSITY[Internet]. 2009;19(2 (56)):105-109. Available from: https://sid.ir/paper/98855/en

IEEE: Copy

H. FAZL ALIZADEH, F. KHAMSEH, B. SOLEYMANI, and A. TAJIK, “COMPARATIVE STUDY OF TOPIRAMATE VERSUS SODIUM VALPROATE IN THE PREVENTION OF MIGRAINE HEADACHES,” MEDICAL SCIENCES JOURNAL OF ISLAMIC AZAD UNIVERSITY, vol. 19, no. 2 (56), pp. 105–109, 2009, [Online]. Available: https://sid.ir/paper/98855/en

Related Journal Papers